Evidence map›Paper›PMID 33813933›Full record

ArticleMedical decision making : an international journal of the Society for Medical Decision Making2021

Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial-Based Cost-Effectiveness Data.

Felix Achana, Daniel Gallacher, Raymond Oppong, Sungwook Kim, Stavros Petrou, James Mason, Michael Crowther

Abstract read
In one paragraph

Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. A Framework for the Estimation of Quality-Adjusted Life-Years Using Joint Models of Longitudinal and Survival Data.Medical decision making : an international journal of the Society for Medical Decision Making · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Felix AchanaNuffield Department of Primary Health Care Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-8727-9125
Daniel GallacherWarwick Evidence, Warwick Medical School, University of Warwick, Coventry, Warwickshire, UK.ORCID 0000-0003-0506-9384
Raymond OppongHealth Economics Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, West Midlands, UK.ORCID 0000-0002-0815-4616
Sungwook KimNuffield Department of Primary Health Care Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-1254-5038
Stavros PetrouNuffield Department of Primary Health Care Sciences, University of Oxford, Oxford, UK.
James MasonClinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
Michael CrowtherBiostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, Leicestershire, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Economic evaluations conducted alongside randomized controlled trials are a popular vehicle for generating high-quality evidence on the incremental cost-effectiveness of competing health care interventions. Typically, in these studies, resource use (and by extension, economic costs) and clinical (or preference-based health) outcomes data are collected prospectively for trial participants to estimate the joint distribution of incremental costs and incremental benefits associated with the intervention. In this article, we extend the generalized linear mixed-model framework to enable simultaneous modeling of multiple outcomes of mixed data types, such as those typically encountered in trial-based economic evaluations, taking into account correlation of outcomes due to repeated measurements on the same individual and other clustering effects. We provide new wrapper functions to estimate the models in Stata and R by maximum and restricted maximum quasi-likelihood and compare the performance of the new routines with alternative implementations across a range of statistical programming packages. Empirical applications using observed and simulated data from clinical trials suggest that the new methods produce broadly similar results as compared with Stata's merlin and gsem commands and a Bayesian implementation in WinBUGS. We highlight that, although these empirical applications primarily focus on trial-based economic evaluations, the new methods presented can be generalized to other health economic investigations characterized by multivariate hierarchical data structures.

Indexed as

Delivery of Health CareBayes TheoremCost-Benefit AnalysisHumansLinear Modelscluster randomised controlled trialscost-effectiveness analysiseconomic evaluation alongside randomised controlled trialsmulticentre and multinational randomised controlled trials

Identifiers

PMID33813933
PMCPMC8295965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.